Lisinopril Tablet
|
Generic Name |
Lisinopril |
|---|---|
|
Strength |
2.5 mg, 5 mg, 10 mg, 20 mg |
|
Form |
Tablet |
|
Packaging |
1 X 10 Tablets |
|
Therapeutic use |
Hypertension, Cardiovascular Agent |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Lisinopril Tablet | 2.5 mg, 5 mg, 10 mg, 20 mg | Hypertension, Cardiovascular Agent | |
| Lisinopril and Hydrochlorothiazide Tablet | 10 mg + 12.5 mg, 5 mg + 12.5 mg | Cardiovascular Agent, Hypertension | |
| Lisinopril and Amlodipine Tablet | 5 mg + 5 mg | Cardiovascular Agent, Angina, Hypertension |
Product Description For Lisinopril Tablet
products details and uses
Lisinopril Tablet Manufacturer, Exporter and Global Supplier in India
Lisinopril Tablet Manufacturer, as a reputed we ensure that every tablet produced meets the highest standards of safety, purity, and efficacy, complying with WHO-GMP and ISO-certified manufacturing protocols. The Lisinopril Tablet is a widely trusted and clinically proven medication used in the management of hypertension and heart failure. Belonging to the class of angiotensin-converting enzyme (ACE) inhibitors, this medicine helps lower blood pressure, improve heart function, and prevent complications such as stroke and kidney damage.
Product Overview
The Lisinopril Tablet works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor responsible for tightening blood vessels. By reducing this process, the medicine helps blood vessels relax, promoting smoother blood flow and reducing the workload on the heart. The result is sustained blood pressure control, enhanced cardiac performance, and improved overall circulatory health.
As a leading Lisinopril Tablet Manufacturer, we provide this product in multiple strengths to cater to varied patient needs. Each batch is formulated with precise composition and undergoes rigorous quality testing to ensure consistent therapeutic performance and extended shelf life.
Uses and Indications
The Lisinopril Tablet is primarily indicated for the following conditions:
-
Hypertension (High Blood Pressure): Helps control and maintain blood pressure at optimal levels.
-
Heart Failure: Improves cardiac output and reduces symptoms of fatigue, breathlessness, and fluid accumulation.
-
Post-Myocardial Infarction: Used as adjunct therapy to increase survival rates and prevent further cardiac events.
-
Diabetic Nephropathy: Helps protect kidney function in patients with type 2 diabetes and hypertension.
Healthcare professionals worldwide prefer sourcing from a reliable Lisinopril Tablet Manufacturer to ensure that the formulation provides consistent bioavailability, potency, and stability.
Dosage and Administration
The dosage of Lisinopril Tablets should be individualized based on the patient’s condition, age, and response to treatment. Typically, it is administered once daily, with or without food, preferably at the same time each day. The dose may start low and gradually increase depending on the blood pressure response. It is essential not to stop or adjust the dose without consulting a healthcare professional.
Being a trusted Lisinopril Tablet Manufacturer, we supply detailed dosage instructions and patient safety information with every pack to support accurate therapeutic administration.
Precautions
Before starting Lisinopril Tablets, patients should be aware of the following precautions:
-
Kidney or Liver Disorders: Dose adjustments may be needed, and renal function should be monitored regularly.
-
Pregnancy and Breastfeeding: Contraindicated during pregnancy as ACE inhibitors can cause fetal harm.
-
Allergic Reactions: Patients with a history of angioedema should avoid using Lisinopril.
-
Hypotension Risk: Patients on diuretics or with volume depletion should start at lower doses.
-
Potassium Supplements: Avoid concurrent use of potassium supplements or salt substitutes unless prescribed by a doctor.
-
Dehydration: Maintain adequate fluid intake, especially during illness, excessive sweating, or diarrhea.
As a certified Lisinopril Tablet Manufacturer, we highlight these precautions clearly to ensure patient safety and proper medical supervision.
Side Effects
The Lisinopril Tablet is generally well tolerated, but some individuals may experience mild to moderate side effects, including:
-
Dizziness or light-headedness, especially after the first dose
-
Persistent dry cough
-
Fatigue or weakness
-
Headache
-
Nausea or diarrhea
-
Low blood pressure
Serious but rare adverse effects may include angioedema (swelling of face, lips, or throat), severe hypotension, or kidney dysfunction. Immediate medical attention is necessary if these occur.
We, as a responsible Lisinopril Tablet Manufacturer, ensure that all safety and pharmacovigilance measures are in place to monitor product performance and patient well-being.
Why Choose Us as Your Trusted Manufacturer
As an established Lisinopril Tablet Manufacturer, we focus on innovation, quality, and reliability. Our state-of-the-art production facilities comply with global regulatory norms, including WHO-GMP, ISO, and FDA-approved manufacturing processes. We offer a variety of packaging options, dosage strengths, and labeling formats suitable for both regulated and semi-regulated markets.
Our commitment to precision formulation, quality assurance, and timely delivery has made us a preferred Lisinopril Tablet Manufacturer among global pharmaceutical distributors, hospitals, and healthcare institutions.
With a dedicated R&D team, efficient logistics, and transparent business ethics, we continue to strengthen our presence as a leading Lisinopril Tablet Manufacturer dedicated to improving global healthcare outcomes through affordable and effective cardiovascular medications.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Lisinopril Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.
